SG11201810160TA - Use of thiophosphate derivatives as skin depigmenting agents - Google Patents

Use of thiophosphate derivatives as skin depigmenting agents

Info

Publication number
SG11201810160TA
SG11201810160TA SG11201810160TA SG11201810160TA SG11201810160TA SG 11201810160T A SG11201810160T A SG 11201810160TA SG 11201810160T A SG11201810160T A SG 11201810160TA SG 11201810160T A SG11201810160T A SG 11201810160TA SG 11201810160T A SG11201810160T A SG 11201810160TA
Authority
SG
Singapore
Prior art keywords
international
geneva
pct
skin
english
Prior art date
Application number
SG11201810160TA
Other languages
English (en)
Inventor
Behrooz Kasraee
Original Assignee
Beyond Cosmeceuticals Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Beyond Cosmeceuticals Sa filed Critical Beyond Cosmeceuticals Sa
Publication of SG11201810160TA publication Critical patent/SG11201810160TA/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/55—Phosphorus compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/02—Preparations for care of the skin for chemically bleaching or whitening the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q5/00—Preparations for care of the hair
    • A61Q5/08—Preparations for bleaching the hair
SG11201810160TA 2016-05-29 2017-05-26 Use of thiophosphate derivatives as skin depigmenting agents SG11201810160TA (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CH6852016 2016-05-29
PCT/EP2017/062746 WO2017207428A1 (en) 2016-05-29 2017-05-26 Use of thiophosphate derivatives as skin depigmenting agents

Publications (1)

Publication Number Publication Date
SG11201810160TA true SG11201810160TA (en) 2018-12-28

Family

ID=60479169

Family Applications (1)

Application Number Title Priority Date Filing Date
SG11201810160TA SG11201810160TA (en) 2016-05-29 2017-05-26 Use of thiophosphate derivatives as skin depigmenting agents

Country Status (8)

Country Link
US (1) US11096881B2 (es)
EP (1) EP3463278B1 (es)
JP (1) JP7084319B2 (es)
CN (1) CN109195578B (es)
BR (1) BR112018074543B1 (es)
ES (1) ES2839503T3 (es)
SG (1) SG11201810160TA (es)
WO (1) WO2017207428A1 (es)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN115884752A (zh) 2020-06-26 2023-03-31 米尼翁大学 用于毛囊调节的组合物、方法及其用途
WO2024056568A1 (en) * 2022-09-12 2024-03-21 Behrooz Kasraee Skin depigmentation composition and use thereof

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3345415A (en) * 1963-01-30 1967-10-03 Eastman Kodak Co N-n-alkylaminoethanethiols
US4424216A (en) * 1979-07-31 1984-01-03 The Rockefeller University Method for the reduction of mucin viscosity
CA1157774A (en) * 1980-07-30 1983-11-29 Anthony Cerami Method for the reduction of mucin viscosity
MC2441A1 (fr) * 1997-07-31 1998-03-11 Exsymol Sa Composition cosmétique utile notamment pour le blanchiment de la peau et agent inhibiteur de la mélanogénèse comprenant une telle composition cosmétique
US6703007B2 (en) * 1999-01-08 2004-03-09 The Procter & Gamble Company Topical compositions comprising functional nucleophiles protected by phosphorus-containing moieties
FR2804960B1 (fr) * 2000-02-11 2005-06-24 Lvmh Rech Nouveaux oligonucleotides et utilisation d'oligonucleotides modulant l'expression de la tyrosinase et de la tyrosinase- related-protein 1 comme agents depigmentants
US6562321B2 (en) * 2000-12-20 2003-05-13 Avon Products, Inc. Compositions and methods for treating hyperpigmentation
ITBS20010027A1 (it) 2001-03-23 2002-09-23 Gen Topics Srl Principio attivo a base di acido lipoico ed acidi grassi polienolici
FR2891737B1 (fr) * 2005-10-11 2008-02-29 Oreal Utilisation de composes c-glycosides pour depigmenter la peau
US9084803B2 (en) 2007-06-29 2015-07-21 Board Of Trustees Of Northern Illinois University Therapeutic uses of glutathione mimics
KR100857725B1 (ko) * 2007-11-21 2008-09-10 한국지질자원연구원 석회석의 정제방법
WO2010107733A2 (en) * 2009-03-16 2010-09-23 Curna, Inc. Treatment of nuclear factor (erythroid-derived 2)-like 2 (nrf2) related diseases by inhibition of natural antisense transcript to nrf2
CH706226B1 (fr) 2012-03-06 2016-03-31 Behrooz Kasraee Préparation pour éclaircir la peau.
FR2988601B1 (fr) * 2012-04-02 2015-04-03 Lucas Meyer Cosmetics Utilisation des activateurs de hif1-alpha dans des compositions cosmetiques permettant d'effectuer un lipomodelage
EP2969030B1 (en) * 2013-03-12 2021-01-13 Avon Products, Inc. A topical lightening composition and methods of use thereof

Also Published As

Publication number Publication date
BR112018074543B1 (pt) 2022-05-24
ES2839503T3 (es) 2021-07-05
CN109195578B (zh) 2021-12-24
EP3463278A1 (en) 2019-04-10
US11096881B2 (en) 2021-08-24
WO2017207428A1 (en) 2017-12-07
BR112018074543A2 (pt) 2019-03-06
EP3463278B1 (en) 2020-10-28
US20200315940A1 (en) 2020-10-08
CN109195578A (zh) 2019-01-11
JP7084319B2 (ja) 2022-06-14
JP2019517479A (ja) 2019-06-24

Similar Documents

Publication Publication Date Title
SG11201810117WA (en) Human platelet lysate derived extracellular vesicles for use in medicine
SG11201901390TA (en) Tetracycline compounds and methods of treatment
SG11201807784SA (en) 3-desoxy derivative and pharmaceutical compositions thereof
SG11201907034PA (en) Methods of treating influenza
SG11201810423XA (en) Pd-1 / pd-l1 inhibitors for cancer treatment
SG11201901996UA (en) Formulations of ( r)-2-amino-3-phenylpropyl carbamate
SG11201807913XA (en) Stabilized soluble pre-fusion rsv f proteins
SG11201807809XA (en) A transient commensal microorganism for improving gut health
SG11201811706RA (en) Process for the preparation of microcapsules
SG11201805311XA (en) Method of treating a mammal, including human, against cancer using methionine and asparagine depletion
SG11201809799WA (en) Tetrahydropyrimidodiazepine and tetrahydropyridodiazepine compounds for treating pain and pain related conditions
SG11201906436VA (en) Novel heterocyclic compound, its preparation method, and pharmaceutical composition comprising the same
SG11201805001UA (en) Method of treating influenza a
SG11201809594WA (en) Nicotine particles and compositions
SG11201903061YA (en) Combination treatments comprising administration of imidazopyrazinones
SG11201810318RA (en) Compounds for promoting hair growth and/or inhibiting or delaying hair loss in humans, and compositions for such uses
SG11201810078PA (en) Stabilized pre-fusion rsv f proteins
SG11201810352XA (en) New antibacterial compounds
SG11201901986SA (en) Process for the manufacture of a solid pharmaceutical adminstration form
SG11201809630RA (en) Nicotine particles
SG11201811708QA (en) Process for the preparation of microcapsules
SG11201408509PA (en) Racecadotril lipid compositions
SG11201901925RA (en) Methods of treating acute kidney injury
SG11201808540SA (en) Methods of treatment for cholestatic and fibrotic diseases
SG11201903521XA (en) Pharmaceutical formulations and methods of making the same